zoledronic acid   Click here for help

GtoPdb Ligand ID: 3177

Synonyms: Aclasta® | CGP-42446 | CGP-42446A | Reclast® | zoledronate | Zometa®
Approved drug PDB Ligand
zoledronic acid is an approved drug (FDA and EMA (2001))
Compound class: Synthetic organic
Comment: Marketed formulations may contain zoledronic acid monohydrate (PubChem CID 121586).
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: zoledronic acid

2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 5
Rotatable bonds 4
Topological polar surface area 172.73
Molecular weight 272
XLogP -4.18
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OP(=O)(C(P(=O)(O)O)(Cn1cncc1)O)O
Isomeric SMILES OP(=O)(C(P(=O)(O)O)(Cn1cncc1)O)O
InChI InChI=1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14)
InChI Key XRASPMIURGNCCH-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
A bisphosphonate used to prevent skeletal fractures in cancer patients and in the treatment of osteoporosis
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Zoledronic acid acts by inhibiting osteoclast activity and reduces bone reabsorption and turnover. This is due to its affinity for the bone mineral matrix component, hydroxyapatite, and its inhibition of enzyme farnesyl diphosphate synthase (FPP synthase, FDPS). FPP synthase inhibition prevents synthesis of the isoprenoid lipids, farnesyl diphosphate and geranylgeranyl diphosphate, which are involved in post-translational farnesylation and geranylgeranylation of small GTPase signalling proteins.
External links Click here for help